In our study, we showed that betulin inhibits the enzymatic activity of ABL1 and perturbs the MAPK/ERK signaling pathway in chronic myelogenous leukemia cells. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.